Table 2

Commonly used pharmacological agents in the treatment of IIH

AgentMode of actionDoseCommon side effectsComments
Acetazolamide▸ Cabrbonic anhydrase inhibitor.
▸ May reduce CSF production by reducing sodium ion transport from the choroid plexus cells
▸ Prepubertal children: start at 25 mg/kg/d in 2–3 divided doses and increase by 25 mg/kg/d to a maximum of 100 mg/kg/day.
▸ Adolescents: start at 1 g/day in 2–3 divided doses and if needed increase by 250 mg/d till a maximum of 4 g/day.12
▸ Metallic taste, tingling sensation in the mouth, paraesthesia and nausea.
▸ Routine urea and electrolytes and blood gases are not recommended unless high doses are used.
▸ Used as firstline treatment.
▸ Success rate quoted in paediatric case reports ranged between 47% and 67%.12
TopiramateWeak carbonic anhydrase inhibitor effect and analgesicStart at 25 mg at night and increase by 25 mg weekly. Maximum dose is typically 100–150 mg.28Word finding difficulties, psychomotor slowing, impaired concentration anorexia, weight loss and sedation.▸ In an open-label study in adults, topiramate was as effective as acetazolamide with the added benefit of reducing weight.28
▸ May work better as an ‘add-on’ to acetazolmaide
FurosemideProbably by diuresis and reduction of sodium transport into the brain1–2 mg/kg/day with or without acetazolamide.12Electrolyte disturbances, postural hypotension▸ Usually reserved as second-line therapy due to risks of electrolytes disturbance on prolonged use.
BumetanideDiuretic, Inhibition of Na+-K+-2Cl co-transport within choroid plexus0.25 mg daily29As for furosemideUsed as monotherapy in a single paediatric case report29
SteroidsUnclear▸ Prednisolone: 1–2 mg/kg/day.
▸ Dexamethasone: 2 mg qds or 0.1–0.75 mg/kg/day in 4 divided doses11
Weight gain, immunosuppression, endocrine disturbances▸ Used as a short-term measure (with acetazolamide) in patients presenting with severe visual failure while awaiting surgical intervention.30
▸ Chronic use not advisable.
  • CSF, cerebrospinal fluid.